SlideShare a Scribd company logo
äéÜìåóç óùëçíáñéÜêç íåöñßôéäá                   ÁÍÔÉÓÔÑÏÖÙÓ, Ç ÑÏÍÉÏÓ ÄÉÁÌÅÓÇ              Analgesic nephropathy is 5-6
                                                ÍÅÖÑÉÔÉÄÁ ÁÑÁÊÔÇÑÉÆÅÔÁÉ                    times more common in
                                                Á Ï:                                       women. This is generally
 áèçóåéò ÅÍÄÏÍÅÖÑÉÊÅÓ ÏÕ ÄÅÍ                                                               attributed to women taking
ÁÖÏÑÏÕÍ ÔÏ Ó ÅÉÑÁÌÁ =                           o ÏÕËÏ ÏÉÇÓÇ                               more analgesics than men.
ÄÉÁÌÅÓÏ ÓÙËÇÍÁÑÉÁÊÅÓ                            o ÉÍÙÓÇ                                    However, a greater sensitivity to
                                                o ÓÙËÇÍÁÑÉÁÊÇ ÁÔÑÏÖÉÁ                      the toxic effects of analgesics
                                                                                           or differences in analgesic
ÓÁÖÙÓ ÓÕ ÍÁ ÓÕÍÕ ÁÑ ÅÉ ÁÑ ÏÌÅÍÇ                                                            metabolism in women cannot
Ó ÅÉÑÁÌÁÔÉÊÇ ÂËÁÂÇ ÓÅ ÅÄÁÖÏÓ                    ÌÅ ÑÏÏÄÅÕÔÉÊÇ ÅÎÅËÉÎÇ ÓÅ ÍÁ
                                                                                           be ruled out.
ÅÃÊÁÔÅÓÔÇÌÅÍÇÓ ÄÉÁÌÅÓÏÓÙËÇÍÁÑÉÁÊÇÓ
ÍÏÓÏÕ Ï ÏÕ ÊÕÑÉÁÑ ÏÕÍ ÏÉ ÅÊÄÇËÙÓÅÉÓ                                                        Acute tubulointerstitial nephritis
ÔÇÓ Ó ÅÉÑÁÌÁÔÉÊÇÓ ÍÏÓÏÕ                         ÌÇ ÁÍÉÓÌÏÉ ÏÎÅÉÁÓ ÄÉÁÌÅÓÇÓ
                                                ÍÅÖÑÉÔÉÄÁÓ :                               (general features)

                                                1..ÁÍÔÉÄÑÁÓÇ Õ ÅÑÅÕÁÉÓÈÇÓÉÁÓ ÓÅ            ÔÕ ÉÊÇ ÅÍÁÑÎÇ = ÔÁ ÅÉÁ
Ç ËÅÏÍ ÔÕ ÉÊÇ ÅÉÊÏÍÁ ÅÎÏÑÌÁÔÁÉ Á Ï                                                         ÅÃÊÁÔÁÓÔÁÓÇ ÏÍÁ ÊÁÔÁ
ÁÍÏÓÏËÉÃÉÊÇ ÖËÅÃÌÏÍÇ                            ÖÁÑÌÁÊÁ
                                                                                           ÊÁÍÏÍÁ ÅÍÔÏÓ ÇÌÅÑÙÍ Á Ï
                                                 ÅÍÉÊÉËËÉÍÇ – ÖÓÁÖ – sulfa drugs           ÔÇÍ ÅÍÁÑÎÇ ÅÊÈÅÓÇÓ ÓÔÏ
                                                                                           ÔÏÎÉÊÏ ÁÑÁÃÏÍÔÁ

                                                2..ÏÎÅÉÁ ÓÙËÇÍÁÑÉÁÊÇ ÍÅÊÑÙÓÇ               ÌÓÁÖ : ÌÅÔÁ Á Ï ÅÊÈÅÓÇ
                                                Á ÏÖÑÁÎÇ ‘Ç ÁËÉÍÄÑÏÌÇÓÇ +                  ÌÇÍÙÍ
                                                ËÏÉÌÙÎÇ                                    o ÅÎÁÍÈÇÌÁ
Acute tubulointerstitial nephritis:                                                        o ÕÑÅÔÏÓ
                                                The kidney is remarkably resistant to      o ÅÙÓÉÍÏÖÉËÉÁ
o Hypersensitivity reactions (eg, drugs,        structural damage in bacterial             o ÅÙÓÉÍÏÖÉËÏÕÑÉÁ
penicillins, sulfa drugs,                       infections, and, in the absence of         o ÁÕÎÇÓÇ ÔÙÍ IgE
nonsteroidal anti-inflammatory drugs [NSAIDs]   obstruction, damage from bacterial
most common)                                    infection in the kidney parenchyma is      ÅÎÁÉÑÅÓÇ = rifampin, ÌÓÁÖ
                                                extremely unlikely to occur
o Immunologic diseases (eg, associated with
lupus, Goodpasture
syndrome)                                                                                  Ç ÉÁ ÄÉÁÌÅÓÇ ÍÅÖÑÉÔÉÄÁ
                                                                                           ÅÍÉÏÔÅ = ÅÎÁÍÈÇÌÁ +
o Acute transplant rejection                                                               ÁÉÌÁÔÏÕÑÉÁ
                                                  transforming growth factor beta
                                                  (TGFâ)                                   Õ ÏÕËÇ ÅÃÊÁÔÁÓÔÁÓÇ
o Infections:
„h Bacterial (must be accompanied by                                                       ÓÙËÇÍÁÑÉÁÊÇÓ ÄÉÁÔÁÑÁ ÇÓ
                                                  = a major participant in                 = Fanconi syndrome :
obstruction or
                                                  fibrogenesis                             ÁÌÉÍÏÎÕÏÕÑÉÁ – ÃËÕÊÏÆÏÕÑÉÁ
reflux)
„h Viral (eg, cytomegalovirus [CMV],                                                       –ÍÅÖÑÏÓÙËÇÍÁÑÉÁÊÇ ÏÎÅÙÓ]
hantavirus, HIV,
                                                  favors accumulation of collagen
hepatitis B)
                                                  and noncollagen basement                   ÑÙÔÅÉÍÏÕÑÉÁ = Á ÏÕÓÉÁÆÅÉ
„h Fungal (eg, histoplasmosis)
                                                  membrane components                      ÅÉÍÁÉ Ç ÉÁ
„h Parasitic (eg, Leishmania, Toxoplasma)
                                                  by direct stimulation of production
                                                  and by
                                                                                           o ÏÕÑÉÍÁËÕÓÇ =
                                                  inhibiting matrix degradation            o ÌÉÊÑÏÓÊÏ ÉÊÇ
                                                  enzymes such as collagenases             ÁÉÌÁÔÏÕÑÉÁÓÔÅÉÑÁ ÕÏÕÑÉÁ
                                                  and metalloproteinases                   o ÌÅ / ÁÍÅÕ ÅÙÓÉÍÏÖÉËÁ
                                                                                           ÁÍ ÊÁÉ Ç ÊËÉÍÉÊÇ ÅÉÊÏÍÁ ÅÉÍÁÉ
÷ñïíéïò ìïñö :                                                                             ÔÕ ÉÊÇ ÊÁÔÁ ÊÁÍÏÍÁ
                                                                                           ÄÉÁÃÍÙÓÇ ÔÉÈÅÔÁÉ ÌÏÍÏ ÌÅÔÁ
 öáñìáêá                                          nuclear factor kappa B (NF-êâ)           Á Ï ÂÉÏØÉÁ
 âáñåá ìåôáëëá
 á ïöñáêôéêç ïõñï áèåéá                           =Activation of nuclear                   ÌÓÁÖ ÔÏÎÉÊÏÔÇÔÁ = ÂÁÑÅÉÁ
 áíïóïëïãéêåò áèçóåéò                             transcription factors
 íåï ëáóéá
 ìåôáâïëéêåò áèçóåéò                              in injured kidney :                      o Antibiotics (eg, penicillins,
 ãåíåôéêåò áèçóåéò                                                                         cephalosporins, sulfa drugs,
 Âáëêáíéêç åíäçìéêç íåöñï áèåéá                   release of proinflammatory               quinolones)
 Chinese herb/aristolochic acid nephropathy       cytokines into the interstitium,         o NSAIDs
                                                  appears to be a major                    o Diuretics (eg, thiazides,
                                                  mechanism of chronic                     furosemide)
                                                  tubulointerstitial inflammation          o Allopurinol
                                                  accompanying proteinuric kidney          o Phenytoin
                                                  diseases                                 o Rifampin
Ç ÊÕÔÔÁÑÉÊÇ ÊÁÔÁÓÔÑÏÖÇ ÓÕÍÅ ÁÃÅÔÁÉ ÔÇÍ                                                     o Interferon alfa
 ÁÑÏÕÓÉÁ ÁÍÔÉÃÏÍÙÍ ÓÅ ÔÏ ÉÊÏ Å É ÅÄÏ,                                                      o Proton pump inhibitors
ÄÉÇÈÇÓ ÌÅ ÊÕÔÔÁÑÁ ÖËÅÃÌÏÍÇÓ,
ÅÍÅÑÃÏ ÏÉÇÓÇ ÑÏÖËÅÃÌÏÍÏÄÙÍ ÊÁÉ                    10-15% of                                Acute allergic interstitial
 ÇÌÅÉÏÔÁÊÔÉÊÙÍ ÊÕÔÔÏÊÉÍÙÍ ÌÅ ÔÅËÉÊÇ ÅÊÂÁÓÇ        all kidney diseases both in the United   nephritis should not be
Ï ÅÉÁ ÅÉÔÅ ÑÏÍÉÏ ÍÅÖÑÉÔÉÄÁ                        States and around                        confused with the acute
                                                  the world                                vasomotor renal insufficiency
ÏÎÅÉÁ ÄÉÁÌÅÓÏÓ ÍÅÖÑÉÔÉÄÁ = ÓÙËÇÍÁÑÉÁÊÇ                                                     that can occur in patients with
ÊÁÔÁÓÔÑÏÖÇ / ÄÕÓËÅÉÔÏÕÑÃÉÁ ÌÅ / ÁÍÅÕ              Mortality/Morbidity                      preexisting underperfusion of
ÍÅÖÑÉÊÇ ÁÍÅ ÁÑÊÅÉÁ ÁÍÅÎÁÑÔÇÔÁ Á Ï ÔÇÍ             o Tubulointerstitial disease may         the kidney.
ÅÊÔÁÓÇ ÔÇÓ ÓÙËÇÍÁÑÉÊÁÇÓ ÊÁÔÁÓÔÑÏÖÇÓ,              progress to end-stage renal
                                                  disease.                                 A unique feature of allergic
 Ç ÍÅÖÑÉÊÇ ÄÕÓËÅÉÔÏÕÑÃÉÁ ÊÁÔÁ ÊÁÍÏÍÁ              o An increased incidence of              interstitial nephritis
ÂÅËÔÉÙÍÅÔÁÉ / ÁÍÁÓÔÑÅÖÅÔÁÉ, ÁÍÔÁÍÁÊËÙÍÔÁÓ         uroepithelial cancers is found among     caused by NSAIDs is that
ÔÇÍ ÁÍÁÃÃÅÍÇÔÉÊÇ ÉÊÁÍÏÔÇÔÁ ÔÙÍ                    patients with analgesic nephropathy,     patients may present with
ÓÙËÇÍÁÑÉÙÍ ÌÅ ÁÍÅ ÁÖÇ ÂÁÓÉÊÇ                      aristolochic acid                        nephrotic
ÌÅÌÂÑÁÍÇ                                          nephropathy, and Balkan endemic          syndrome. In such patients,
                                                  nephropathy.                             massive proteinuria with
                                                                                           hypoalbuminemia and edema
                                                                                           are prese
Antibiotic-induced acute                           Analgesic nephropathy                 Lead nephropathy
tubulointerstitial nephritis
                                                   ôï ë ïí óõ÷íü áßôéï, á ü              íåöñï Üèåéá + ïõñéê
                                                                                         áñèñßôéäá
óå íïóïêïìåéáêü áóèåí õ ü áãùã ãéá                 óõíäõáóìü :
ëïéìÿîåéò                                            phenacetin, aspirin, and caffeine
                                                     phenacetin + acetaminophen           áßäåò = åãêåöáëï Üèåéá +
  åîÜíèçìá                                           NSAIDs and acetaminophen             ÍÁ äéêçí fanconi
  åùóçíüöéëá ^^ óå ïñü êáé ï ñá
  áéìáôïõñßá                                       è ëåá 6çò - 7çò äåêáåôßáò             Õ ÅÑÔÁÓÇ !
     éá ñùôåéíïõñßá : <1 g/d
                                                   õ üíïéá óå äéáëëåß ïõóá               ÄÉÁÃÍÙÓÇ = EDTA
âéïøßá                                              õåëïíåöñßôéäá :
                                                                                         lead mobilization test
  åíßïôå åùóéíüöéëá
  åíßïôå ill-defined granulomas are present          í êñùóç èçëÿí
                                                     áéìáôïõñßá                          ËÁÍÈÁÓÌÅÓ ÄÃÍ/ÓÅÉÓ
                                                     â èéï Üëãïò åíßïôå + á üöñáîç
                                                     ëïßìùîç
                                                                                         ïõñéê íåöñï Üèåéá
                                                   %% å áóâåóôÿóåéò èçëÿí                õ åñôáóéê
                                                                                         íåöñïóêë ñùóç
 rifampin
                                                   áíáéìßá + óôåßñá õïõñßá +
 óå å áíá÷ïñ ãçóç ìåôá´á ï 1 äéáóôçìá =             ñùôåúíïõñßá
 óõó÷ ôéóç ìå äéÜìåóç íåöñéôéäá
                                                                                         Obstructive uropathy
 åíßïôå :                                          %% åî ëéîç óå ÍÁ

   ++ åëáöñ ò Üëõóïé áíåõ á üäåéîçò                % óõó÷ ôéóç ìå ïõñïå éèçëéáêÜ         o prostate disease,
   ìõåëÿìáôïò                                      åï ëÜóìáôá                            o stone disease,
                                                                                         o neoplasm, and
   ++ IgG circulating antirifampin êáé                                                   o retroperitoneal fibrosis
   åíÜ ïèåóç óôç âáóéê ìåìâñÜíç
                                                                                         ìåôáî Üëëùí ñïêáëåß
   ÁÍÅÕ ÅÙÓÉÍÏÖÉËÉÁÓ                               Lithium nephropathy                   äéÜìåóç óùëçíáñéáê íüóï

                                                   óôï 50 %                              = ñùôåúíïõñßá +
   ÂÕÈÉÏ ÁËÃÏÓ + Õ ÅÑÔÁÓÇ + ÃÑÉ ÙÄÅÓ                                                     õ åñêáëéáéìßá, óùëçíáñéáê
   ÓÕÍÄÑÏÌÏ + ÏÍÁ ÌÅ ÏËÉÃÏÕÑÉÁ                     äéáôáñá÷ óôï Ü ù :                    ïî ùóç
                                                   o polyuria,
                                                   o concentrating defect,               TORCH infections
                                                   o down-regulation of aquaporin-2      Toxoplasmosis Other (syphilis)
                                                                                         Rubella Cytomegalovirus
                                                                                         (CMV) Herpes simplex virus
miscellaneous agents                               ó áíßùò ÷ñüíéïò ìïñö , ìåôÜ á ï       (HSV)
                                                   å áíçëëåéì íá å éóüäéá ôïîéêüôçôáò
 Hantavirus, CMV, and HIV are common               á ï õøçë ò óõãêåíôñÿóåéò ïñï
                                                                                         = ïõñçôçñïêõóôéê íüóïò ìå
                                                                                         ó åéñáìáïóêë ñõíóç êáé
 HIV : äéÜìåóç + ó åéñáìáôïíåöñßôéäá                                                     íåöñùóéêü ïõ èá äÿóåé
      åóôéáê ôìçìáôéê óêë ñõíóç                                                          óôçí ñí ëéêï æù äéÜìåóç
                                                                                         íåöñßôéäá áêüìç êáé åáí ç
                                                     Cyclosporine- and
 ÂÁÊÔÇÑÉÁ : ó Üíéá Üíåõ á üöñáîçò                                                         áëéíäñüìçóç äéïñèÿèçêå
                                                     tacrolimus-induced                  íùñßò
                                                     nephropathy
 éóôï ëÜóìùóç - öõìáôßùóç : ÄÄ           ñüêëçóç     = chronic transplant nephropathy    Superimposed infection and
                                                                                         pyelonephritis often
                                                     óå ìåôáìïó÷å óåéò                   complicate
                                                       áñ, íåöñüò, ìõïêÜñäéï             obstruction
                                                     ü÷é óå ìõåëï , ìéêñüôåñç äüóç !
                                                                                         óå äéáëëåß ïõóåò
                                                                                         ïõñïëïéìÿîåéò ñïäéÜèåóç
 Chronic tubulointerstitial nephritis                óõó÷ ôéóç ìå áããåéïó ó áóç, ï       ãéá ammonium
                                                     ìç÷áíéóìüò = äßêçí á üññéøçò        magnesium phosphate
 óõ÷íÜ ôõ÷áßï å ñçìá                                 ìïó÷å ìáôïò                         ëßèïõò, öáõëïò ê êëïò
  Üíåõ óõìôùìÜôùí
     éá åùò óïâáñ õ åñôáóç
  äéêçí óùëçíáñéêá ò ïî ùóçò = ^êñåáôéíßíç
  äéêçí fanconi                                      áíáì íïíôáé :
     éá ñùôåéíïõñßá
                                                     õ   ñôáóç + õ åñêáëéáéìßá
 ÷áñáêôçñéóôéêü = low molecular weight (eg,
   immunoglobulin light chains, beta2                êõêëïó ïñßíç : + õ ïìáãíçóéáéìßá
   microglobulin,
   lysozyme, peptide hormones)                       èñïìâïôéê ìéêñïáããåéï Üèåéá

 = âëÜâç óôï åãã ò óùëçíÜñéï

 ôåêìçñßùóç
   äéÜìåóç ßíùóç
   óùëçíáñéáê áôñïößá
   áããåéáê óêë ñõíóç
   äé èçóç á ü ìïíï ñçíá
Balkan endemic nephropathy                          á åéêïíßóåéò
Atherosclerotic kidney disease
                                                 åñéâáëëïíôéêüò áñÜãùí                              õ     ñç÷ïò
ïíïìáóßåò =                                     ÷ùñßò õ åñôáóç                                          õäñïí öñùóç
o Échemic nephropathy,                          óçìáíôéê áíáéìßá                                        ëßèïé
o renovascular disease, and
o nephrosclerosis                               >40% ïõñïå éèçëéáêÜ íåï ëÜóìáôá óôï                     ê.ö ì ãåèïò äåí á ïêëåßåé
                                                áíÿôåñï ïõñï ïéçôéêü                                    ÁÉÍ, åíäå÷ïì íùò
                                                                                                        áíáóôñ øéìç
elderly white males who smoke                   %% ÍÁ ôåëéêï óôáäßïõ                                    ìéêñü ì ãåèïò = ìç
individuals with dyslipidemia and other                                                                 áíáóôñ øéìç âëÜâç
atherosclerotic phenomena
                                                                                                    õ ñç÷ïò + KUB ëÜêá
                                                Chinese herb åñé ÷ïíôá aristolochic acid            ÄÄ óêéåñÿí / äéáöáíÿí ëßèùí
Often, these patients have hypertension, not    êáé ïõ ÷ñçóéìï ïéï íôáé ãéá á ÿëåéá
necessarily severe, with elevated serum         âÜñïõò
creatinine and urea nitrogen and proteinuria,                                                       CT
1-2 g/d                                          ñïïäåõôéê äéÜìåóç óùëçíáñéêá                       áíáì íïíôáé å áóâåóôÿóåéò
                                                íåöñßôéäá êáé äéÜìåóç éíùóç                         óôï õåëïêáëõêéêü
= ïñåßá âñáä ôåñç á ï ïôé óå íåöñùóéêü
ë.÷ ó ä - íåöñï Üèåéá                                                                               ÃÜëéï
                                                                                                      áñíçôéêü = äåí á ïêëåßåé ôç
                                                                                                      íüóï
äéÜãíùóç                                        Differential Diagnoses                                èåôéêï = ìç åéäéêü, áí
                                                  Acute Renal Failure                                 õ Üñ÷åé õ üíïéá,
  êëéíéê
                                                  Glomerulonephritis, Acute                           å áëçèå åé
  ôåêìçñßùóç á åéêïíéóôéê á ïêáë ôïõóá
                                                  Urinary Tract Obstruction
  áèçñïóêë ñùóç ôùí íåöñéêÿí áñôçñéù´í
  äåí á éôåßôáé âéïøßá óõí èùò
                                                Other Problems to Be Considered
                                                 Radiation nephritis
äåí õ Üñ÷åé åéäéê áíôéìåôÿ éóç, áãùã             Toxic nephropathies
 íáíôé õ ñôáóçò, êáé áíôéëé éäáéìéê


                                                                                                    ëïé    ò åîåôÜóåéò

                                                 Laboratory Studies                                 EDTA lead mobilization test

 Cholesterol microembolic disease and                                                               ç áñïõóßá ìïë âäïõ óôï
                                                 åùóéíïöéëßá :
 nephropathy                                      ç áñïõóßá ôçò âïçèÜ, áëëá´äåí åéßíáé              áßìá åßíáé ÷ñ óéìç óå ïîåßá
                                                  åéäéê                                             ìüíï íüóï
   áõèüñìçôç                                      á ïõóéÜæåé óå ÁÉÍ = Acute
   õ ü áãùã ìå áíôé çêôéêÜ                        tubulointerstitial nephritis in children
                                                  á ïõóéÜæåé óå ÌÓÁÖ ôïîéêüôçôá                      ïéïôéêüò ñïóéïñéóìüò
   ìåôÜ á ü äéáãíùóôéêï ò áããåéáêï ò                                                                 ñùôåúíïõñßáò
   êáèåôçñéáóìï ò
                                                                                                    ÷áçëïõ ìïñéáêï âáñïõò
 á ïóôáèñï ïßçóç ôïõ áèçñÿìáôïò êáé                                                                 êáé åëáöñ ò Üëõóïé
                                                 Blood chemistry:
 á ïöñÜîåéò á ï ìéêñï ìâïëá íåöñéêÿí
 ôñé÷ïåéäÿí á ü âåëïíïåéäåßò êñõóôÜëëïõò                                                            = âëÜâç óôï Ü ù
                                                   ÷áìçëá äéôôáíèñáêéêÜ = ïîåßäùóç
                                                   ÷áìçëü êÜëéï = âëÜâç óôï Ü ù
 áìöéâëçóôñïåéä ò : Hollenhorst plaques                                                             ÷ñïíéïó ÁÉÍ
                                                   õøçëü êÜëéï + ÷áìçëÜ äéôôáíèñáêéêÜ =
 ÊÍÓ                                                                                                âáëêáíéê íåöñßôéäá
                                                   óùëçíáñéáê ïî ùóç ôõ ïó 4 [ ÌÓÁÖ,
 Üêñá : livedo reticularis                                                                          êÜäìéï
                                                   ìüëõâäïò]

 åíßïôå óõóôçìáôéê íüóïò
 ^^ ESR
                                                 ïõñéíÜëõóç :
  õñ ôéï
 ÷áìçëü óõì ë ñùìá
                                                   áéìáôïõñßá
 ëåõêïêõôôÜñùóç
                                                    ñùôåúíïõñßá
 åùóéíïöéëßá
                                                    õïõñßá ìå / áíåõ âáêô ñéá
                                                   ëåõêïêõôôáñéêïß ê ëéíäñïé
 äåí õ Üñ÷åé èåñá åßá åéäéê
                                                 ìéêñïóêï éê

                                                   ê ëéíäñïé
                                                   ëåõêïêõôôáñéêïß ê ëéíäñïé
                                                   åùóéíüöéëá
Metabolic disorders and                            êñ óôáëëïé
nephropathy
                                                 If allergic interstitial nephritis is suspected,
 õ åñáóâåóôéáéìßá, áêüìç êáé ç áñïäéê            send a cytospin specimen to determine if
 êõóôéê ßíùóç                                    eosinophils are in the urine
 chronic potassium depletion


õ ïëåé ÿìåíç óõì     êíùóç, ïëõïõñßá

áíáì íùíôáé íåöñéê ò å áóâåóôÿóåéò, ç
ëéèßáóç óõíéóôÜ ä óêïëç ôç äéá÷åßñçóç
å é ëüêåò
äéá÷åßñçóç
                                             õ    ñôáóç
äéáêï     ôïîéêï    áñÜãïíôá
                                             çëåêôñïëõôéê ò äéáôáñá÷ ò
óå ìç âåëôßùóç åíôüó çìåñùí :
Prednisone 0.5-2 mg/kg/d PO, taper as         ÍÁ ïõ á áéôåß äéë çóç
condition improves; single am dose
safer for long-term use, but divided doses
have greater antiinflammatory
effect


Modifies the body's immune response to
diverse stimuli
                                                 ñüãíùóç
o May decrease inflammation by reversing
increased capillary permeability and
o suppressing PMN [= PML =                   Allergic interstitial nephritis:
polymorphonuclear leukocytes ] activity.
o Stabilizes lysosomal membranes and         êáôÜ êáíüíá õ ï÷ùñåß
o suppresses lymphocytes and antibody
production
                                             Cholesterol microembolic kidney
                                             disease:
monitor for hypokalemia with
coadministration of diuretics                äåí õ Üñ÷åé ë ñçò âåëôßùóç, ßáóç



Chelating agents
                                             Chronic tubulointerstitial
Succimer (Chemet)                            nephritides:
Metal chelator, analog of dimercaprol.
                                             êáôáë ãåé óå ÍÁ áëëÜ åßíáé
Used in lead poisoning.                      ëéãüôåñï å éèåôéê á ü ôéò
                                             ó åéñáìáôïíåöñßôéäåò
Particularly useful in children with lead
blood levels >45 mcg/dL.


Edetate calcium disodium (Calcium
Disodium Versenate)

For lead chelation. Only the calcium
disodium preparation
should be used.

More Related Content

What's hot

43 renal pathology
43 renal pathology43 renal pathology
43 renal pathology
Dang Thanh Tuan
 
Tubulointerstitial nephritis
Tubulointerstitial nephritisTubulointerstitial nephritis
Tubulointerstitial nephritis
Swati Wadhai
 
Disease affecting tubules and interstitium
Disease affecting tubules and interstitiumDisease affecting tubules and interstitium
Disease affecting tubules and interstitium
essamramdan
 
Renal tubulo interstitial diseases
Renal tubulo interstitial diseasesRenal tubulo interstitial diseases
Renal tubulo interstitial diseases
Medesun Healthcare Solutions LLC
 
THE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASES
THE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASESTHE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASES
THE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASES
Dr. Roopam Jain
 
TUBULAR & TUBULOINTERSTITIAL DISEASES
TUBULAR & TUBULOINTERSTITIAL DISEASESTUBULAR & TUBULOINTERSTITIAL DISEASES
TUBULAR & TUBULOINTERSTITIAL DISEASES
Dr. Roopam Jain
 
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Sufia Husain
 
Tubulointerstitial diseases
Tubulointerstitial diseasesTubulointerstitial diseases
Tubulointerstitial diseases
edwinchowyw
 
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. GawadInfection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
NephroTube - Dr.Gawad
 
Tubulointerstitial diseases of Kidney
Tubulointerstitial diseases of KidneyTubulointerstitial diseases of Kidney
Tubulointerstitial diseases of Kidney
Usman Shams
 
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
Sufia Husain
 
Pathophysiology of Glomerulonephritis
Pathophysiology of GlomerulonephritisPathophysiology of Glomerulonephritis
Pathophysiology of Glomerulonephritis
Jegan Nadar
 
1.glomerulonephritis
1.glomerulonephritis1.glomerulonephritis
1.glomerulonephritis
PNK SINGH
 
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Sufia Husain
 
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Sufia Husain
 
Renal pathology
Renal pathologyRenal pathology
Renal pathology
Gopi sankar
 
Glomerulus and nephrotic & nephritic syndrome
Glomerulus and nephrotic & nephritic syndromeGlomerulus and nephrotic & nephritic syndrome
Glomerulus and nephrotic & nephritic syndrome
essamramdan
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
Eneutron
 
Renal inflammatory disease
Renal inflammatory diseaseRenal inflammatory disease
Renal inflammatory disease
jgash
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
Tsegaye Melaku
 

What's hot (20)

43 renal pathology
43 renal pathology43 renal pathology
43 renal pathology
 
Tubulointerstitial nephritis
Tubulointerstitial nephritisTubulointerstitial nephritis
Tubulointerstitial nephritis
 
Disease affecting tubules and interstitium
Disease affecting tubules and interstitiumDisease affecting tubules and interstitium
Disease affecting tubules and interstitium
 
Renal tubulo interstitial diseases
Renal tubulo interstitial diseasesRenal tubulo interstitial diseases
Renal tubulo interstitial diseases
 
THE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASES
THE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASESTHE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASES
THE KIDNEY: TUBULAR & TUBULOINTERSTITIAL DISEASES
 
TUBULAR & TUBULOINTERSTITIAL DISEASES
TUBULAR & TUBULOINTERSTITIAL DISEASESTUBULAR & TUBULOINTERSTITIAL DISEASES
TUBULAR & TUBULOINTERSTITIAL DISEASES
 
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
 
Tubulointerstitial diseases
Tubulointerstitial diseasesTubulointerstitial diseases
Tubulointerstitial diseases
 
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. GawadInfection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad
 
Tubulointerstitial diseases of Kidney
Tubulointerstitial diseases of KidneyTubulointerstitial diseases of Kidney
Tubulointerstitial diseases of Kidney
 
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
 
Pathophysiology of Glomerulonephritis
Pathophysiology of GlomerulonephritisPathophysiology of Glomerulonephritis
Pathophysiology of Glomerulonephritis
 
1.glomerulonephritis
1.glomerulonephritis1.glomerulonephritis
1.glomerulonephritis
 
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
 
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
 
Renal pathology
Renal pathologyRenal pathology
Renal pathology
 
Glomerulus and nephrotic & nephritic syndrome
Glomerulus and nephrotic & nephritic syndromeGlomerulus and nephrotic & nephritic syndrome
Glomerulus and nephrotic & nephritic syndrome
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
Renal inflammatory disease
Renal inflammatory diseaseRenal inflammatory disease
Renal inflammatory disease
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 

Similar to 17 Nephritis Interstitial__

23 Urinalysis
23 Urinalysis23 Urinalysis
23 Urinalysis
kdiwavvou
 
Puerperium abnoraml
Puerperium abnoramlPuerperium abnoraml
Puerperium abnoraml
Snehlata Parashar
 
Abnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdfAbnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdf
KaranSingh321255
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
О. Оскар
 
Endocrine 2016 all
Endocrine 2016 allEndocrine 2016 all
Urinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing ManagementUrinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing Management
Swatilekha Das
 
6 Viral Hepatitis
6 Viral Hepatitis6 Viral Hepatitis
6 Viral Hepatitis
kdiwavvou
 
10 Hypera Ld Diagram
10 Hypera Ld Diagram10 Hypera Ld Diagram
10 Hypera Ld Diagram
kdiwavvou
 
UTI.pptx
UTI.pptxUTI.pptx
UTI.pptx
SOUMYA PURANAM
 
Urinary Incontinence
Urinary IncontinenceUrinary Incontinence
Urinary Incontinence
jhardesty
 
Tavanic levofloxacin
Tavanic levofloxacinTavanic levofloxacin
Tavanic levofloxacin
Ahmed Elrheem
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
Bananijjeh
 
Tetanus
TetanusTetanus
Tetanus
baha alosy
 
Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)
Amira Badr
 
Complications of artificial reproductive technology
Complications of artificial reproductive technologyComplications of artificial reproductive technology
Complications of artificial reproductive technology
sunitafeme
 
Causes of vertigo
Causes of vertigoCauses of vertigo
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
Priyatham Kasaraneni
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
Partha Pratim
 
8.presentation on male reproductive system [autosaved]
8.presentation on male reproductive system [autosaved]8.presentation on male reproductive system [autosaved]
8.presentation on male reproductive system [autosaved]
PoojaDagar3
 
Presentation on male reproductive system by pooja
Presentation on male reproductive system by poojaPresentation on male reproductive system by pooja
Presentation on male reproductive system by pooja
PoojaDagar3
 

Similar to 17 Nephritis Interstitial__ (20)

23 Urinalysis
23 Urinalysis23 Urinalysis
23 Urinalysis
 
Puerperium abnoraml
Puerperium abnoramlPuerperium abnoraml
Puerperium abnoraml
 
Abnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdfAbnormal puerperium and its management.pdf
Abnormal puerperium and its management.pdf
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Endocrine 2016 all
Endocrine 2016 allEndocrine 2016 all
Endocrine 2016 all
 
Urinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing ManagementUrinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing Management
 
6 Viral Hepatitis
6 Viral Hepatitis6 Viral Hepatitis
6 Viral Hepatitis
 
10 Hypera Ld Diagram
10 Hypera Ld Diagram10 Hypera Ld Diagram
10 Hypera Ld Diagram
 
UTI.pptx
UTI.pptxUTI.pptx
UTI.pptx
 
Urinary Incontinence
Urinary IncontinenceUrinary Incontinence
Urinary Incontinence
 
Tavanic levofloxacin
Tavanic levofloxacinTavanic levofloxacin
Tavanic levofloxacin
 
Urinary tract infection
Urinary tract infectionUrinary tract infection
Urinary tract infection
 
Tetanus
TetanusTetanus
Tetanus
 
Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)Drug therapy during_pregnancy (1)
Drug therapy during_pregnancy (1)
 
Complications of artificial reproductive technology
Complications of artificial reproductive technologyComplications of artificial reproductive technology
Complications of artificial reproductive technology
 
Causes of vertigo
Causes of vertigoCauses of vertigo
Causes of vertigo
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
 
8.presentation on male reproductive system [autosaved]
8.presentation on male reproductive system [autosaved]8.presentation on male reproductive system [autosaved]
8.presentation on male reproductive system [autosaved]
 
Presentation on male reproductive system by pooja
Presentation on male reproductive system by poojaPresentation on male reproductive system by pooja
Presentation on male reproductive system by pooja
 

More from kdiwavvou

56 Establishing A Bedside Diagnosis Of Hypovolemia
56    Establishing A Bedside Diagnosis Of Hypovolemia56    Establishing A Bedside Diagnosis Of Hypovolemia
56 Establishing A Bedside Diagnosis Of Hypovolemia
kdiwavvou
 
55 Aldosterone Inhibitors Diuretic S
55    Aldosterone Inhibitors  Diuretic S55    Aldosterone Inhibitors  Diuretic S
55 Aldosterone Inhibitors Diuretic S
kdiwavvou
 
52 Respir Atory Patt Er Ns
52 Respir Atory   Patt Er Ns52 Respir Atory   Patt Er Ns
52 Respir Atory Patt Er Ns
kdiwavvou
 
50 Myeloproliferative Disease
50 Myeloproliferative Disease50 Myeloproliferative Disease
50 Myeloproliferative Disease
kdiwavvou
 
46 Electrolyte Replacement
46 Electrolyte Replacement46 Electrolyte Replacement
46 Electrolyte Replacement
kdiwavvou
 
46 Electrolytes
46 Electrolytes46 Electrolytes
46 Electrolytes
kdiwavvou
 
35 G I Functional Dearangements
35  G I Functional Dearangements35  G I Functional Dearangements
35 G I Functional Dearangements
kdiwavvou
 
42 Lipids Diagram
42 Lipids Diagram42 Lipids Diagram
42 Lipids Diagram
kdiwavvou
 
42 Lipids Diagram
42 Lipids Diagram42 Lipids Diagram
42 Lipids Diagram
kdiwavvou
 
42 2 Dyslipidemia
42 2 Dyslipidemia42 2 Dyslipidemia
42 2 Dyslipidemia
kdiwavvou
 
44 Ecg Final
44 Ecg Final44 Ecg Final
44 Ecg Final
kdiwavvou
 
44 Ecg Final
44 Ecg Final44 Ecg Final
44 Ecg Final
kdiwavvou
 
44 E C G
44 E C G44 E C G
44 E C G
kdiwavvou
 
38 Hypertension
38 Hypertension38 Hypertension
38 Hypertension
kdiwavvou
 
37 Vitamins
37 Vitamins37 Vitamins
37 Vitamins
kdiwavvou
 
36 A N T I H Y P E R T E N S I V E D R U G S
36  A N T I H Y P E R T E N S I V E  D R U G S36  A N T I H Y P E R T E N S I V E  D R U G S
36 A N T I H Y P E R T E N S I V E D R U G Skdiwavvou
 
36 Antipyretensive Drugs
36 Antipyretensive Drugs36 Antipyretensive Drugs
36 Antipyretensive Drugskdiwavvou
 
36 Antihypertensive Drugs
36 Antihypertensive Drugs36 Antihypertensive Drugs
36 Antihypertensive Drugskdiwavvou
 
Gi Functional Dearangements
Gi Functional DearangementsGi Functional Dearangements
Gi Functional Dearangements
kdiwavvou
 

More from kdiwavvou (20)

56 Establishing A Bedside Diagnosis Of Hypovolemia
56    Establishing A Bedside Diagnosis Of Hypovolemia56    Establishing A Bedside Diagnosis Of Hypovolemia
56 Establishing A Bedside Diagnosis Of Hypovolemia
 
55 Aldosterone Inhibitors Diuretic S
55    Aldosterone Inhibitors  Diuretic S55    Aldosterone Inhibitors  Diuretic S
55 Aldosterone Inhibitors Diuretic S
 
52 Respir Atory Patt Er Ns
52 Respir Atory   Patt Er Ns52 Respir Atory   Patt Er Ns
52 Respir Atory Patt Er Ns
 
50 Myeloproliferative Disease
50 Myeloproliferative Disease50 Myeloproliferative Disease
50 Myeloproliferative Disease
 
46 Electrolyte Replacement
46 Electrolyte Replacement46 Electrolyte Replacement
46 Electrolyte Replacement
 
46 Electrolytes
46 Electrolytes46 Electrolytes
46 Electrolytes
 
35 G I Functional Dearangements
35  G I Functional Dearangements35  G I Functional Dearangements
35 G I Functional Dearangements
 
42 Lipids Diagram
42 Lipids Diagram42 Lipids Diagram
42 Lipids Diagram
 
42 Lipids Diagram
42 Lipids Diagram42 Lipids Diagram
42 Lipids Diagram
 
42 2 Dyslipidemia
42 2 Dyslipidemia42 2 Dyslipidemia
42 2 Dyslipidemia
 
44 Ecg Final
44 Ecg Final44 Ecg Final
44 Ecg Final
 
44 Ecg Final
44 Ecg Final44 Ecg Final
44 Ecg Final
 
44 E C G
44 E C G44 E C G
44 E C G
 
38 Hypertension
38 Hypertension38 Hypertension
38 Hypertension
 
37 Vitamins
37 Vitamins37 Vitamins
37 Vitamins
 
36 A N T I H Y P E R T E N S I V E D R U G S
36  A N T I H Y P E R T E N S I V E  D R U G S36  A N T I H Y P E R T E N S I V E  D R U G S
36 A N T I H Y P E R T E N S I V E D R U G S
 
36 Antipyretensive Drugs
36 Antipyretensive Drugs36 Antipyretensive Drugs
36 Antipyretensive Drugs
 
32 I R S
32   I R S32   I R S
32 I R S
 
36 Antihypertensive Drugs
36 Antihypertensive Drugs36 Antihypertensive Drugs
36 Antihypertensive Drugs
 
Gi Functional Dearangements
Gi Functional DearangementsGi Functional Dearangements
Gi Functional Dearangements
 

Recently uploaded

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 

Recently uploaded (20)

Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 

17 Nephritis Interstitial__

  • 1. äéÜìåóç óùëçíáñéÜêç íåöñßôéäá ÁÍÔÉÓÔÑÏÖÙÓ, Ç ÑÏÍÉÏÓ ÄÉÁÌÅÓÇ Analgesic nephropathy is 5-6 ÍÅÖÑÉÔÉÄÁ ÁÑÁÊÔÇÑÉÆÅÔÁÉ times more common in Á Ï: women. This is generally áèçóåéò ÅÍÄÏÍÅÖÑÉÊÅÓ ÏÕ ÄÅÍ attributed to women taking ÁÖÏÑÏÕÍ ÔÏ Ó ÅÉÑÁÌÁ = o ÏÕËÏ ÏÉÇÓÇ more analgesics than men. ÄÉÁÌÅÓÏ ÓÙËÇÍÁÑÉÁÊÅÓ o ÉÍÙÓÇ However, a greater sensitivity to o ÓÙËÇÍÁÑÉÁÊÇ ÁÔÑÏÖÉÁ the toxic effects of analgesics or differences in analgesic ÓÁÖÙÓ ÓÕ ÍÁ ÓÕÍÕ ÁÑ ÅÉ ÁÑ ÏÌÅÍÇ metabolism in women cannot Ó ÅÉÑÁÌÁÔÉÊÇ ÂËÁÂÇ ÓÅ ÅÄÁÖÏÓ ÌÅ ÑÏÏÄÅÕÔÉÊÇ ÅÎÅËÉÎÇ ÓÅ ÍÁ be ruled out. ÅÃÊÁÔÅÓÔÇÌÅÍÇÓ ÄÉÁÌÅÓÏÓÙËÇÍÁÑÉÁÊÇÓ ÍÏÓÏÕ Ï ÏÕ ÊÕÑÉÁÑ ÏÕÍ ÏÉ ÅÊÄÇËÙÓÅÉÓ Acute tubulointerstitial nephritis ÔÇÓ Ó ÅÉÑÁÌÁÔÉÊÇÓ ÍÏÓÏÕ ÌÇ ÁÍÉÓÌÏÉ ÏÎÅÉÁÓ ÄÉÁÌÅÓÇÓ ÍÅÖÑÉÔÉÄÁÓ : (general features) 1..ÁÍÔÉÄÑÁÓÇ Õ ÅÑÅÕÁÉÓÈÇÓÉÁÓ ÓÅ ÔÕ ÉÊÇ ÅÍÁÑÎÇ = ÔÁ ÅÉÁ Ç ËÅÏÍ ÔÕ ÉÊÇ ÅÉÊÏÍÁ ÅÎÏÑÌÁÔÁÉ Á Ï ÅÃÊÁÔÁÓÔÁÓÇ ÏÍÁ ÊÁÔÁ ÁÍÏÓÏËÉÃÉÊÇ ÖËÅÃÌÏÍÇ ÖÁÑÌÁÊÁ ÊÁÍÏÍÁ ÅÍÔÏÓ ÇÌÅÑÙÍ Á Ï ÅÍÉÊÉËËÉÍÇ – ÖÓÁÖ – sulfa drugs ÔÇÍ ÅÍÁÑÎÇ ÅÊÈÅÓÇÓ ÓÔÏ ÔÏÎÉÊÏ ÁÑÁÃÏÍÔÁ 2..ÏÎÅÉÁ ÓÙËÇÍÁÑÉÁÊÇ ÍÅÊÑÙÓÇ ÌÓÁÖ : ÌÅÔÁ Á Ï ÅÊÈÅÓÇ Á ÏÖÑÁÎÇ ‘Ç ÁËÉÍÄÑÏÌÇÓÇ + ÌÇÍÙÍ ËÏÉÌÙÎÇ o ÅÎÁÍÈÇÌÁ Acute tubulointerstitial nephritis: o ÕÑÅÔÏÓ The kidney is remarkably resistant to o ÅÙÓÉÍÏÖÉËÉÁ o Hypersensitivity reactions (eg, drugs, structural damage in bacterial o ÅÙÓÉÍÏÖÉËÏÕÑÉÁ penicillins, sulfa drugs, infections, and, in the absence of o ÁÕÎÇÓÇ ÔÙÍ IgE nonsteroidal anti-inflammatory drugs [NSAIDs] obstruction, damage from bacterial most common) infection in the kidney parenchyma is ÅÎÁÉÑÅÓÇ = rifampin, ÌÓÁÖ extremely unlikely to occur o Immunologic diseases (eg, associated with lupus, Goodpasture syndrome) Ç ÉÁ ÄÉÁÌÅÓÇ ÍÅÖÑÉÔÉÄÁ ÅÍÉÏÔÅ = ÅÎÁÍÈÇÌÁ + o Acute transplant rejection ÁÉÌÁÔÏÕÑÉÁ transforming growth factor beta (TGFâ) Õ ÏÕËÇ ÅÃÊÁÔÁÓÔÁÓÇ o Infections: „h Bacterial (must be accompanied by ÓÙËÇÍÁÑÉÁÊÇÓ ÄÉÁÔÁÑÁ ÇÓ = a major participant in = Fanconi syndrome : obstruction or fibrogenesis ÁÌÉÍÏÎÕÏÕÑÉÁ – ÃËÕÊÏÆÏÕÑÉÁ reflux) „h Viral (eg, cytomegalovirus [CMV], –ÍÅÖÑÏÓÙËÇÍÁÑÉÁÊÇ ÏÎÅÙÓ] hantavirus, HIV, favors accumulation of collagen hepatitis B) and noncollagen basement ÑÙÔÅÉÍÏÕÑÉÁ = Á ÏÕÓÉÁÆÅÉ „h Fungal (eg, histoplasmosis) membrane components ÅÉÍÁÉ Ç ÉÁ „h Parasitic (eg, Leishmania, Toxoplasma) by direct stimulation of production and by o ÏÕÑÉÍÁËÕÓÇ = inhibiting matrix degradation o ÌÉÊÑÏÓÊÏ ÉÊÇ enzymes such as collagenases ÁÉÌÁÔÏÕÑÉÁÓÔÅÉÑÁ ÕÏÕÑÉÁ and metalloproteinases o ÌÅ / ÁÍÅÕ ÅÙÓÉÍÏÖÉËÁ ÁÍ ÊÁÉ Ç ÊËÉÍÉÊÇ ÅÉÊÏÍÁ ÅÉÍÁÉ ÷ñïíéïò ìïñö : ÔÕ ÉÊÇ ÊÁÔÁ ÊÁÍÏÍÁ ÄÉÁÃÍÙÓÇ ÔÉÈÅÔÁÉ ÌÏÍÏ ÌÅÔÁ öáñìáêá nuclear factor kappa B (NF-êâ) Á Ï ÂÉÏØÉÁ âáñåá ìåôáëëá á ïöñáêôéêç ïõñï áèåéá =Activation of nuclear ÌÓÁÖ ÔÏÎÉÊÏÔÇÔÁ = ÂÁÑÅÉÁ áíïóïëïãéêåò áèçóåéò transcription factors íåï ëáóéá ìåôáâïëéêåò áèçóåéò in injured kidney : o Antibiotics (eg, penicillins, ãåíåôéêåò áèçóåéò cephalosporins, sulfa drugs, Âáëêáíéêç åíäçìéêç íåöñï áèåéá release of proinflammatory quinolones) Chinese herb/aristolochic acid nephropathy cytokines into the interstitium, o NSAIDs appears to be a major o Diuretics (eg, thiazides, mechanism of chronic furosemide) tubulointerstitial inflammation o Allopurinol accompanying proteinuric kidney o Phenytoin diseases o Rifampin Ç ÊÕÔÔÁÑÉÊÇ ÊÁÔÁÓÔÑÏÖÇ ÓÕÍÅ ÁÃÅÔÁÉ ÔÇÍ o Interferon alfa ÁÑÏÕÓÉÁ ÁÍÔÉÃÏÍÙÍ ÓÅ ÔÏ ÉÊÏ Å É ÅÄÏ, o Proton pump inhibitors ÄÉÇÈÇÓ ÌÅ ÊÕÔÔÁÑÁ ÖËÅÃÌÏÍÇÓ, ÅÍÅÑÃÏ ÏÉÇÓÇ ÑÏÖËÅÃÌÏÍÏÄÙÍ ÊÁÉ 10-15% of Acute allergic interstitial ÇÌÅÉÏÔÁÊÔÉÊÙÍ ÊÕÔÔÏÊÉÍÙÍ ÌÅ ÔÅËÉÊÇ ÅÊÂÁÓÇ all kidney diseases both in the United nephritis should not be Ï ÅÉÁ ÅÉÔÅ ÑÏÍÉÏ ÍÅÖÑÉÔÉÄÁ States and around confused with the acute the world vasomotor renal insufficiency ÏÎÅÉÁ ÄÉÁÌÅÓÏÓ ÍÅÖÑÉÔÉÄÁ = ÓÙËÇÍÁÑÉÁÊÇ that can occur in patients with ÊÁÔÁÓÔÑÏÖÇ / ÄÕÓËÅÉÔÏÕÑÃÉÁ ÌÅ / ÁÍÅÕ Mortality/Morbidity preexisting underperfusion of ÍÅÖÑÉÊÇ ÁÍÅ ÁÑÊÅÉÁ ÁÍÅÎÁÑÔÇÔÁ Á Ï ÔÇÍ o Tubulointerstitial disease may the kidney. ÅÊÔÁÓÇ ÔÇÓ ÓÙËÇÍÁÑÉÊÁÇÓ ÊÁÔÁÓÔÑÏÖÇÓ, progress to end-stage renal disease. A unique feature of allergic Ç ÍÅÖÑÉÊÇ ÄÕÓËÅÉÔÏÕÑÃÉÁ ÊÁÔÁ ÊÁÍÏÍÁ o An increased incidence of interstitial nephritis ÂÅËÔÉÙÍÅÔÁÉ / ÁÍÁÓÔÑÅÖÅÔÁÉ, ÁÍÔÁÍÁÊËÙÍÔÁÓ uroepithelial cancers is found among caused by NSAIDs is that ÔÇÍ ÁÍÁÃÃÅÍÇÔÉÊÇ ÉÊÁÍÏÔÇÔÁ ÔÙÍ patients with analgesic nephropathy, patients may present with ÓÙËÇÍÁÑÉÙÍ ÌÅ ÁÍÅ ÁÖÇ ÂÁÓÉÊÇ aristolochic acid nephrotic ÌÅÌÂÑÁÍÇ nephropathy, and Balkan endemic syndrome. In such patients, nephropathy. massive proteinuria with hypoalbuminemia and edema are prese
  • 2. Antibiotic-induced acute Analgesic nephropathy Lead nephropathy tubulointerstitial nephritis ôï ë ïí óõ÷íü áßôéï, á ü íåöñï Üèåéá + ïõñéê áñèñßôéäá óå íïóïêïìåéáêü áóèåí õ ü áãùã ãéá óõíäõáóìü : ëïéìÿîåéò phenacetin, aspirin, and caffeine phenacetin + acetaminophen áßäåò = åãêåöáëï Üèåéá + åîÜíèçìá NSAIDs and acetaminophen ÍÁ äéêçí fanconi åùóçíüöéëá ^^ óå ïñü êáé ï ñá áéìáôïõñßá è ëåá 6çò - 7çò äåêáåôßáò Õ ÅÑÔÁÓÇ ! éá ñùôåéíïõñßá : <1 g/d õ üíïéá óå äéáëëåß ïõóá ÄÉÁÃÍÙÓÇ = EDTA âéïøßá õåëïíåöñßôéäá : lead mobilization test åíßïôå åùóéíüöéëá åíßïôå ill-defined granulomas are present í êñùóç èçëÿí áéìáôïõñßá ËÁÍÈÁÓÌÅÓ ÄÃÍ/ÓÅÉÓ â èéï Üëãïò åíßïôå + á üöñáîç ëïßìùîç ïõñéê íåöñï Üèåéá %% å áóâåóôÿóåéò èçëÿí õ åñôáóéê íåöñïóêë ñùóç rifampin áíáéìßá + óôåßñá õïõñßá + óå å áíá÷ïñ ãçóç ìåôá´á ï 1 äéáóôçìá = ñùôåúíïõñßá óõó÷ ôéóç ìå äéÜìåóç íåöñéôéäá Obstructive uropathy åíßïôå : %% åî ëéîç óå ÍÁ ++ åëáöñ ò Üëõóïé áíåõ á üäåéîçò % óõó÷ ôéóç ìå ïõñïå éèçëéáêÜ o prostate disease, ìõåëÿìáôïò åï ëÜóìáôá o stone disease, o neoplasm, and ++ IgG circulating antirifampin êáé o retroperitoneal fibrosis åíÜ ïèåóç óôç âáóéê ìåìâñÜíç ìåôáî Üëëùí ñïêáëåß ÁÍÅÕ ÅÙÓÉÍÏÖÉËÉÁÓ Lithium nephropathy äéÜìåóç óùëçíáñéáê íüóï óôï 50 % = ñùôåúíïõñßá + ÂÕÈÉÏ ÁËÃÏÓ + Õ ÅÑÔÁÓÇ + ÃÑÉ ÙÄÅÓ õ åñêáëéáéìßá, óùëçíáñéáê ÓÕÍÄÑÏÌÏ + ÏÍÁ ÌÅ ÏËÉÃÏÕÑÉÁ äéáôáñá÷ óôï Ü ù : ïî ùóç o polyuria, o concentrating defect, TORCH infections o down-regulation of aquaporin-2 Toxoplasmosis Other (syphilis) Rubella Cytomegalovirus (CMV) Herpes simplex virus miscellaneous agents ó áíßùò ÷ñüíéïò ìïñö , ìåôÜ á ï (HSV) å áíçëëåéì íá å éóüäéá ôïîéêüôçôáò Hantavirus, CMV, and HIV are common á ï õøçë ò óõãêåíôñÿóåéò ïñï = ïõñçôçñïêõóôéê íüóïò ìå ó åéñáìáïóêë ñõíóç êáé HIV : äéÜìåóç + ó åéñáìáôïíåöñßôéäá íåöñùóéêü ïõ èá äÿóåé åóôéáê ôìçìáôéê óêë ñõíóç óôçí ñí ëéêï æù äéÜìåóç íåöñßôéäá áêüìç êáé åáí ç Cyclosporine- and ÂÁÊÔÇÑÉÁ : ó Üíéá Üíåõ á üöñáîçò áëéíäñüìçóç äéïñèÿèçêå tacrolimus-induced íùñßò nephropathy éóôï ëÜóìùóç - öõìáôßùóç : ÄÄ ñüêëçóç = chronic transplant nephropathy Superimposed infection and pyelonephritis often óå ìåôáìïó÷å óåéò complicate áñ, íåöñüò, ìõïêÜñäéï obstruction ü÷é óå ìõåëï , ìéêñüôåñç äüóç ! óå äéáëëåß ïõóåò ïõñïëïéìÿîåéò ñïäéÜèåóç Chronic tubulointerstitial nephritis óõó÷ ôéóç ìå áããåéïó ó áóç, ï ãéá ammonium ìç÷áíéóìüò = äßêçí á üññéøçò magnesium phosphate óõ÷íÜ ôõ÷áßï å ñçìá ìïó÷å ìáôïò ëßèïõò, öáõëïò ê êëïò Üíåõ óõìôùìÜôùí éá åùò óïâáñ õ åñôáóç äéêçí óùëçíáñéêá ò ïî ùóçò = ^êñåáôéíßíç äéêçí fanconi áíáì íïíôáé : éá ñùôåéíïõñßá õ ñôáóç + õ åñêáëéáéìßá ÷áñáêôçñéóôéêü = low molecular weight (eg, immunoglobulin light chains, beta2 êõêëïó ïñßíç : + õ ïìáãíçóéáéìßá microglobulin, lysozyme, peptide hormones) èñïìâïôéê ìéêñïáããåéï Üèåéá = âëÜâç óôï åãã ò óùëçíÜñéï ôåêìçñßùóç äéÜìåóç ßíùóç óùëçíáñéáê áôñïößá áããåéáê óêë ñõíóç äé èçóç á ü ìïíï ñçíá
  • 3. Balkan endemic nephropathy á åéêïíßóåéò Atherosclerotic kidney disease åñéâáëëïíôéêüò áñÜãùí õ ñç÷ïò ïíïìáóßåò = ÷ùñßò õ åñôáóç õäñïí öñùóç o Échemic nephropathy, óçìáíôéê áíáéìßá ëßèïé o renovascular disease, and o nephrosclerosis >40% ïõñïå éèçëéáêÜ íåï ëÜóìáôá óôï ê.ö ì ãåèïò äåí á ïêëåßåé áíÿôåñï ïõñï ïéçôéêü ÁÉÍ, åíäå÷ïì íùò áíáóôñ øéìç elderly white males who smoke %% ÍÁ ôåëéêï óôáäßïõ ìéêñü ì ãåèïò = ìç individuals with dyslipidemia and other áíáóôñ øéìç âëÜâç atherosclerotic phenomena õ ñç÷ïò + KUB ëÜêá Chinese herb åñé ÷ïíôá aristolochic acid ÄÄ óêéåñÿí / äéáöáíÿí ëßèùí Often, these patients have hypertension, not êáé ïõ ÷ñçóéìï ïéï íôáé ãéá á ÿëåéá necessarily severe, with elevated serum âÜñïõò creatinine and urea nitrogen and proteinuria, CT 1-2 g/d ñïïäåõôéê äéÜìåóç óùëçíáñéêá áíáì íïíôáé å áóâåóôÿóåéò íåöñßôéäá êáé äéÜìåóç éíùóç óôï õåëïêáëõêéêü = ïñåßá âñáä ôåñç á ï ïôé óå íåöñùóéêü ë.÷ ó ä - íåöñï Üèåéá ÃÜëéï áñíçôéêü = äåí á ïêëåßåé ôç íüóï äéÜãíùóç Differential Diagnoses èåôéêï = ìç åéäéêü, áí Acute Renal Failure õ Üñ÷åé õ üíïéá, êëéíéê Glomerulonephritis, Acute å áëçèå åé ôåêìçñßùóç á åéêïíéóôéê á ïêáë ôïõóá Urinary Tract Obstruction áèçñïóêë ñùóç ôùí íåöñéêÿí áñôçñéù´í äåí á éôåßôáé âéïøßá óõí èùò Other Problems to Be Considered Radiation nephritis äåí õ Üñ÷åé åéäéê áíôéìåôÿ éóç, áãùã Toxic nephropathies íáíôé õ ñôáóçò, êáé áíôéëé éäáéìéê ëïé ò åîåôÜóåéò Laboratory Studies EDTA lead mobilization test Cholesterol microembolic disease and ç áñïõóßá ìïë âäïõ óôï åùóéíïöéëßá : nephropathy ç áñïõóßá ôçò âïçèÜ, áëëá´äåí åéßíáé áßìá åßíáé ÷ñ óéìç óå ïîåßá åéäéê ìüíï íüóï áõèüñìçôç á ïõóéÜæåé óå ÁÉÍ = Acute õ ü áãùã ìå áíôé çêôéêÜ tubulointerstitial nephritis in children á ïõóéÜæåé óå ÌÓÁÖ ôïîéêüôçôá ïéïôéêüò ñïóéïñéóìüò ìåôÜ á ü äéáãíùóôéêï ò áããåéáêï ò ñùôåúíïõñßáò êáèåôçñéáóìï ò ÷áçëïõ ìïñéáêï âáñïõò á ïóôáèñï ïßçóç ôïõ áèçñÿìáôïò êáé êáé åëáöñ ò Üëõóïé Blood chemistry: á ïöñÜîåéò á ï ìéêñï ìâïëá íåöñéêÿí ôñé÷ïåéäÿí á ü âåëïíïåéäåßò êñõóôÜëëïõò = âëÜâç óôï Ü ù ÷áìçëá äéôôáíèñáêéêÜ = ïîåßäùóç ÷áìçëü êÜëéï = âëÜâç óôï Ü ù áìöéâëçóôñïåéä ò : Hollenhorst plaques ÷ñïíéïó ÁÉÍ õøçëü êÜëéï + ÷áìçëÜ äéôôáíèñáêéêÜ = ÊÍÓ âáëêáíéê íåöñßôéäá óùëçíáñéáê ïî ùóç ôõ ïó 4 [ ÌÓÁÖ, Üêñá : livedo reticularis êÜäìéï ìüëõâäïò] åíßïôå óõóôçìáôéê íüóïò ^^ ESR ïõñéíÜëõóç : õñ ôéï ÷áìçëü óõì ë ñùìá áéìáôïõñßá ëåõêïêõôôÜñùóç ñùôåúíïõñßá åùóéíïöéëßá õïõñßá ìå / áíåõ âáêô ñéá ëåõêïêõôôáñéêïß ê ëéíäñïé äåí õ Üñ÷åé èåñá åßá åéäéê ìéêñïóêï éê ê ëéíäñïé ëåõêïêõôôáñéêïß ê ëéíäñïé åùóéíüöéëá Metabolic disorders and êñ óôáëëïé nephropathy If allergic interstitial nephritis is suspected, õ åñáóâåóôéáéìßá, áêüìç êáé ç áñïäéê send a cytospin specimen to determine if êõóôéê ßíùóç eosinophils are in the urine chronic potassium depletion õ ïëåé ÿìåíç óõì êíùóç, ïëõïõñßá áíáì íùíôáé íåöñéê ò å áóâåóôÿóåéò, ç ëéèßáóç óõíéóôÜ ä óêïëç ôç äéá÷åßñçóç
  • 4. å é ëüêåò äéá÷åßñçóç õ ñôáóç äéáêï ôïîéêï áñÜãïíôá çëåêôñïëõôéê ò äéáôáñá÷ ò óå ìç âåëôßùóç åíôüó çìåñùí : Prednisone 0.5-2 mg/kg/d PO, taper as ÍÁ ïõ á áéôåß äéë çóç condition improves; single am dose safer for long-term use, but divided doses have greater antiinflammatory effect Modifies the body's immune response to diverse stimuli ñüãíùóç o May decrease inflammation by reversing increased capillary permeability and o suppressing PMN [= PML = Allergic interstitial nephritis: polymorphonuclear leukocytes ] activity. o Stabilizes lysosomal membranes and êáôÜ êáíüíá õ ï÷ùñåß o suppresses lymphocytes and antibody production Cholesterol microembolic kidney disease: monitor for hypokalemia with coadministration of diuretics äåí õ Üñ÷åé ë ñçò âåëôßùóç, ßáóç Chelating agents Chronic tubulointerstitial Succimer (Chemet) nephritides: Metal chelator, analog of dimercaprol. êáôáë ãåé óå ÍÁ áëëÜ åßíáé Used in lead poisoning. ëéãüôåñï å éèåôéê á ü ôéò ó åéñáìáôïíåöñßôéäåò Particularly useful in children with lead blood levels >45 mcg/dL. Edetate calcium disodium (Calcium Disodium Versenate) For lead chelation. Only the calcium disodium preparation should be used.